Skip to content

ACRYSOF® SN6AT6 (REF SN6AT6.190)Recalls & reported problems

Alcon Laboratories, Inc. · AcrySof(R) IQ TORIC ASTIGMATISM IOL, SINGLE-PIECE ACRYLIC FOLDABLE LENS, UV WITH BLUE LIGHTFILTER, 13.0mm LENGTH, 6.0mm BICONVEX TORICASPHERIC OPTIC, 3.75 D CYLINDER. · Class 3 · Implant

All models of ACRYSOF (353)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00380652274319), received between Jul 31, 2021 and Mar 4, 2024 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Failure to Eject” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Failure to Eject1

Patient problems

  • Insufficient Information1
  • Toxic Anterior Segment Syndrome (TASS)1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 4, 2024Failure to Eject; Failure to Eject

    A HEALTHCARE PROFESSIONAL REPORTED THAT DURING THE INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE OBSERVED INJECTION ISSUE WITH LENS INTO THE EYE. THERE WAS PATIENT IMPACT. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Insufficient Information

    MAUDE report 18825101 ↗
  • InjuryJul 31, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PHARMACIST REPORTED THAT A PATIENT EXPERIENCED TOXIC ANTERIOR SEGMENT SYNDROME (TASS) AFTER USE OF A VISCOELASTIC PRODUCT IN AN INTRAOCULAR LENS IMPLANTATION SURGERY. ADDITIONAL INFORMATION HAS BEEN REQUESTED. THIS FILE REPRESENTS PATIENT 2 OF 2 FROM THIS FACILITY. ADDITIONAL INFORMATION RECEIVED INDICATED THAT THE SURGEON ALSO SUSPECTED THE INTRAOCULAR LENS (IOL) ALSO AS A CAUSE OF EVENT. ADDITIONAL INFORMATION RECEIVED INDICATED THAT TASS WITH DIFFUSE CORNEAL EDEMA IN A CATARACT SURGERY IN THE LEFT EYE WAS OBSERVED.

    Patient problems: Toxic Anterior Segment Syndrome (TASS)

    MAUDE report 12257191 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page